Glenmark Life Sciences was up over one percent in the afternoon trade following a CNBC Awaaz report that parent Glenmark Pharmaceuticals was looking to reduce its stake in the company without sharing the details.
Moneycontrol couldn’t verify the development independently.
As of June 30, Glenmark Pharmaceuticals held an 82.84 percent stake in the company. Glenmark Pharmaceuticals chairman and managing director Glenn Saldanha said in an earnings conference call for Q1FY24, “We have a 7-8 percent sell-down requirement by law and we are working on it.”
The Securities and Exchange Board of India (SEBI) mandates that promoters can’t hold more than 75 percent in a company.
“Glenmark has three years to bring the public shareholding to 25 percent, and the timeline is up to August 2024,” Glenmark Pharma’s executive director and global chief financial officer VS Mani said in the call.
Also read ChrysCapital joins race to buy Glenmark Life Sciences for around Rs 7,000 cr
Nirma submitted its binding bid for Glenmark Pharmaceuticals stake in August. Private Equity firm ChyrsCapital was also in a race to take over Glenmark Pharmaceuticals stake.
Follow our live blog for more updates
In the April-to-June quarter, Glenmark Life Sciences reported an 18 percent year-on-year (YoY) growth in revenue at Rs 578.45 crore. Net profit rose 24 percent to Rs 135.45 crore.
The company reported earnings before interest, taxes, depreciation, and amortisation (EBITDA) of Rs 195 crore, up 24.8 percent YoY.
At 12.59, the share was trading at 639 on the National Stock Exchange, up 0.61 percent.
Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
